Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMPASS CLAUDICATION: Rivaroxaban + Aspirin in PAD
NCT04853719Phase 4Completed
- Sponsor
- Science Valley Research Institute
- Start
- Apr 2021
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rivaroxaban in peripheral artery disease (PAD), sponsored by Science Valley Research Institute. Started Apr 2021; status: completed.
02
Drugs
rivaroxaban
03
Conditions
peripheral artery disease (PAD)
Beyond the preview
Go deeper on NCT04853719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04853719.